Term: | Abnormal cardiac test |
|
Accession: | HP:0500015
|
browse the term
|
Definition: | Abnormal test result of cardiovascular physiology. |
|
|
|
G
|
ACE
|
angiotensin I converting enzyme
|
susceptibility
|
IAGP
|
associated with Hypertension, Essential;DNA:deletion:intron:IVS16+1464-1751del
|
RGD |
PMID:17625392 |
RGD:8142350 |
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G
|
CDK8
|
cyclin dependent kinase 8
|
susceptibility
|
IAGP
|
DNA:SNP:intron: (rs7992670) (human)
|
RGD |
PMID:34815954 |
RGD:155260314 |
NCBI chr13:26,254,129...26,405,238
Ensembl chr13:26,254,104...26,420,982
|
|
G
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
susceptibility
|
IAGP
|
DNA:polymorphism, haplotype: :HLA-DQA1*0101, HLA-DQA1*0103, HLA-DQA1*0301 (human)
|
RGD |
PMID:29029143 |
RGD:126925989 |
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
|
|
|
G
|
MMP9
|
matrix metallopeptidase 9
|
susceptibility
|
IAGP
|
DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538)
|
RGD |
PMID:17893005 |
RGD:7207049 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G
|
MTHFR
|
methylenetetrahydrofolate reductase
|
susceptibility
|
IAGP
|
associated with Kidney Failure, Chronic;DNA:transition:cds:g.677C>T (rs1801133)
|
RGD |
PMID:19272686 |
RGD:6893548 |
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
|
|
|
G
|
AKAP9
|
A-kinase anchoring protein 9
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
|
|
G
|
ANK2
|
ankyrin 2
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221
|
|
G
|
CACNA1C
|
calcium voltage-gated channel subunit alpha1 C
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr12:1,970,780...2,697,950
Ensembl chr12:1,970,772...2,697,950
|
|
G
|
CALM1
|
calmodulin 1
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268
|
|
G
|
CALM2
|
calmodulin 2
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 2:47,160,082...47,176,936
Ensembl chr 2:47,160,084...47,176,921
|
|
G
|
CALM3
|
calmodulin 3
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782
|
|
G
|
CAV3
|
caveolin 3
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 3:8,733,802...8,746,758
Ensembl chr 3:8,733,802...8,841,808
|
|
G
|
KCNE1
|
potassium voltage-gated channel subfamily E regulatory subunit 1
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr21:34,446,688...34,512,210
Ensembl chr21:34,446,688...34,512,214
|
|
G
|
KCNE2
|
potassium voltage-gated channel subfamily E regulatory subunit 2
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr21:34,364,006...34,371,381
Ensembl chr21:34,180,729...34,371,381
|
|
G
|
KCNH2
|
potassium voltage-gated channel subfamily H member 2
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G
|
KCNJ5
|
potassium inwardly rectifying channel subfamily J member 5
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr11:128,891,356...128,921,163
Ensembl chr11:128,891,356...128,921,163
|
|
G
|
KCNQ1
|
potassium voltage-gated channel subfamily Q member 1
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
|
|
G
|
NOS1AP
|
nitric oxide synthase 1 adaptor protein
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 1:162,069,691...162,370,475
Ensembl chr 1:162,069,691...162,370,475
|
|
G
|
SCN10A
|
sodium voltage-gated channel alpha subunit 10
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 3:38,696,807...38,816,217
Ensembl chr 3:38,696,802...38,816,286
|
|
G
|
SCN4B
|
sodium voltage-gated channel beta subunit 4
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr11:118,133,377...118,152,823
Ensembl chr11:118,133,377...118,152,888
|
|
G
|
SCN5A
|
sodium voltage-gated channel alpha subunit 5
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,743
|
|
G
|
SNTA1
|
syntrophin alpha 1
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr20:33,407,957...33,443,763
Ensembl chr20:33,407,957...33,443,763
|
|
G
|
TBX5
|
T-box transcription factor 5
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr12:114,353,911...114,408,442
Ensembl chr12:114,353,911...114,408,442
|
|
G
|
TRDN
|
triadin
|
|
IAGP
|
|
HPO |
|
ORPHA:101016 |
NCBI chr 6:123,216,339...123,636,950
Ensembl chr 6:123,216,339...123,637,189
|
|
|
G
|
DSG2
|
desmoglein 2
|
|
IAGP
|
|
HPO |
PMID:16505173 |
MIM:610193 |
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,497,624...31,551,351
|
|
G
|
SVIL
|
supervillin
|
|
IAGP
|
|
HPO |
PMID:32779703 |
MIM:619040 |
NCBI chr10:29,457,338...29,736,936
Ensembl chr10:29,457,338...29,736,959
|
|
|
G
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
IAGP
|
|
HPO |
PMID:36745799 |
MIM:620375 |
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G
|
NPPA
|
natriuretic peptide A
|
|
IAGP
|
|
HPO |
|
ORPHA:1344 |
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
IAGP
|
DNA:SNP:intron: (rs6080699)
|
RGD |
PMID:20036365 |
RGD:6483554 |
NCBI chr20:17,226,107...17,484,578
Ensembl chr20:17,226,107...17,484,578
|
|
G
|
PSMB9
|
proteasome 20S subunit beta 9
|
|
IAGP
|
|
HPO |
PMID:33727065 |
MIM:620796 |
NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,860,734
|
|
G
|
SCN5A
|
sodium voltage-gated channel alpha subunit 5
|
|
IAGP
|
|
HPO |
|
ORPHA:1344 |
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,743
|
|
G
|
TTR
|
transthyretin
|
|
IAGP
|
|
HPO |
|
ORPHA:85451 |
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
|
|
Term paths to the root
|